Ulinastatin reduces urinary sepsis‑related inflammation by upregulating IL‑10 and downregulating TNF‑α levels

Chen,Xian; Wang,Yi; Luo,Hongmei; Luo,Zhigang; Liu,Lisha; Xu,Wujun; Zhang,Tao; Yang,Ning; Long,Xiangyang; Zhu,Neng; Xie,Huang; Liu,Jun

doi:10.3892/mmr.2013.1480

July 2013 Volume 8 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

July 2013 Volume 8 Issue 1

Full Size Image

Article

Ulinastatin reduces urinary sepsis‑related inflammation by upregulating IL‑10 and downregulating TNF‑α levels

Authors:
- Xian Chen
- Yi Wang
- Hongmei Luo
- Zhigang Luo
- Lisha Liu
- Wujun Xu
- Tao Zhang
- Ning Yang
- Xiangyang Long
- Neng Zhu
- Huang Xie
- Jun Liu
View Affiliations / Copyright

Affiliations: Department of Urology, The Second Affiliated Hospital of University of South China, Hengyang, Hunan 421001, P.R. China, Department of Histology and Embryology, University of South China, Hengyang, Hunan 421001, P.R. China
Pages: 29-34
|
Published online on: May 16, 2013

https://doi.org/10.3892/mmr.2013.1480
Expand metrics +

Abstract

The aim of the present study was to determine the efficacy of ulinastatin (UTI) for the treatment of sepsis and to investigate the associated molecular mechanisms. Twenty‑four male rabbits were randomly divided into 4 groups, the normal, sham, sepsis model and UTI groups, each containing 6 rabbits. Serum levels of interleukin (IL)‑10 and tumor necrosis factor‑α (TNF‑α) were measured by enzyme‑linked immunosorbent assay (ELISA). Liver, kidney and lung tissues were stained with hematoxylin and eosin (H&E) 36 h after sacrifice and morphological changes were observed under an optical microscope. The expression levels of IL‑10 and TNF‑α proteins in rabbit kidney tissue in each group were determined by immunohistochemical detection and western blot analysis. ELISA results indicated that, compared with the sepsis model, IL‑10 levels were significantly higher in the UTI treatment group (183.91±11.521 pg/ml) at 36 h (P=0.000), while serum TNF‑α concentration decreased significantly in the UTI treatment group (31.637±2.770 pg/ml; P=0.000). Results of western blot analysis were consistent with the immunohistochemistry, indicating that UTI upregulates IL‑10 and downregulates TNF‑α levels. In the current study, UTI was demonstrated to effectively treat urinary sepsis and alleviate the inflammatory response in tissues. These effects were mediated by the upregulation of IL‑10 and downregulation of TNF‑α levels.

View Figures

View References

1	Brun-Buisson C: The epidemiology of the systemic inflammatory response. Intensive Care Med. 26(Suppl 1): S64–S74. 2000. View Article : Google Scholar
2	Hotchkiss RS and Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med. 348:138–150. 2003. View Article : Google Scholar : PubMed/NCBI
3	Brunkhorst FM: Epidemiology, economy and practice - results of the German study on prevalence by the competence network sepsis (SepNet). Anasthesiol Intensivmed Notfallmed Schmerzther. 41:43–44. 2006.(In German).
4	Yamamoto Y, Fujita K, Nakazawa S, et al: Clinical characteristics and risk factors for septic shock in patients receiving emergency drainage for acute pyelonephritis with upper urinary tract calculi. BMC Urol. 12:42012. View Article : Google Scholar
5	Yao Yongming, Chai Jiake and Li Hongyuan: Modern Sepsis Theory and Practice. Science Press; Beijing: pp. 155–288. 2005
6	Saji T: Clinical utility of ulinastatin, urinary protease inhibitor in acute Kawasaki disease. Nihon Rinsho. 66:343–348. 2008.(In Japanese).
7	Tani T, Aoki H, Yoshioka T, Lin KJ and Kodama M: Treatment of septic shock with a protease inhibitor in a canine model: a prospective, randomized, controlled trial. Crit Care Med. 21:925–930. 1993. View Article : Google Scholar : PubMed/NCBI
8	Shao YM, Zhang LQ, Deng LH and Yao HG: Clinical study on effects of ulinastatin on patients with systemic inflammatory response syndrome. Chin Wei Zhong Bing Ji Jiu Med. 17:228–230. 2005.(In Chinese).
9	Chen X, Wang Y, Luo H, et al: β-elemene acts as an antitumor factor and downregulates the expression of survivin, Bcl-xL and Mta-1. Mol Med Rep. 6:989–995. 2012.
10	Lu X, Wang Y, Luo H, Qiu W, Han H, Chen X and Yang L: β-elemene inhibits the proliferation of T24 bladder carcinoma cells through upregulation of the expression of Smad4. Mol Med Rep. 7:513–518. 2013.
11	Ono S, Ichikura T and Mochizuki H: The pathogenesis of the systemic inflammatory response syndrome and compensatory antiinflammatory response syndrome following surgical stress. Nihon Geka Gakkai Zasshi. 104:499–505. 2003.(In Japanese).
12	Levels JH, Lemaire LC, van den Ende AE, van Deventer SJ and van Lanschot JJ: Lipid composition and lipopolysaccharide binding capacity of lipoproteins in plasma and lymph of patients with systemic inflammatory response syndrome and multiple organ failure. Crit Care Med. 31:1647–1653. 2003. View Article : Google Scholar
13	Kocabaş E, Sarikçioğlu A, Aksaray N, Seydaoğlu G, Seyhun Y and Yaman A: Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis. Turk J Pediatr. 49:7–20. 2007.PubMed/NCBI
14	Ni Choileain N and Redmond HP: The immunological consequences of injury. Surgeon. 4:23–31. 2006.
15	Zhang Q, Li Q, Mao BL, Qian GS, Xu JC and Chen ZT: Studies on the expression of mRNA of anti- and pro-inflammatory cytokines in acute lung injury induced by lipopolysaccharide in rat. Chin Wei Zhong Bing Ji Jiu Med. 16:585–588. 2004.(In Chinese).
16	Moore KW, de Waal Malefyt R, Coffman RL and O’Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 19:683–765. 2001. View Article : Google Scholar : PubMed/NCBI
17	Sewnath ME, Olszyna DP, Birjmohun R, ten Kate FJ, Gouma DJ and van Der Poll T: IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance. J Immunol. 166:6323–6331. 2001. View Article : Google Scholar : PubMed/NCBI
18	Molor-Erdene P, Okajima K, Isobe H, Uchiba M, Harada N and Okabe H: Urinary trypsin inhibitor reduces LPS-induced hypotension by suppressing tumor necrosis factor-alpha production through inhibition of Egr-1 expression. Am J Physiol Heart Circ Physiol. 288:H1265–H1271. 2005. View Article : Google Scholar
19	Cao YZ, Tu YY, Chen X, et al: Protective effect of ulinastatin against murine models of sepsis: inhibition of TNF-α and IL-6 and augmentation of IL-10 and IL-13. Exp Toxicol Pathol. 64:543–547. 2012.PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Ulinastatin reduces urinary sepsis‑related inflammation by upregulating IL‑10 and downregulating TNF‑α levels

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Related Articles